Heparin and Heparan Sulfate Block Angiotensin II-Induced Hypertrophy in Cultured Neonatal Rat Cardiomyocytes: A Possible Role of Intrinsic Heparin-like Molecules in Regulation of Cardiomyocyte Hypertrophy

Circulation

Volumn 93, Issue 4, 1996, Pages 810-816

  Akimoto, Hajime ^a   Ito, Hiroshi ^a   Tanaka, Masato ^a   Adachi, Susumu ^a   Hata, Mimi ^a   Lin, Meihong ^a   Fujisaki, Hiroyuki ^a   Marumo, Fumiaki ^a   Hiroe, Michiaki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Angiotensin; Heparin; Hypertrophy

Indexed keywords

ANGIOTENSIN; CANDESARTAN; HEPARAN SULFATE; HEPARIN;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL CULTURE; CELL POPULATION; CELL STRUCTURE; DRUG INDUCED DISEASE; EXTRACELLULAR MATRIX; GENE EXPRESSION; GROWTH INHIBITION; HEART HYPERTROPHY; HEART MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT;

ANGIOTENSIN II; ANIMALS; CARDIOMEGALY; CELLS, CULTURED; HEART; HEPARIN; HEPARIN LYASE; HEPARITIN SULFATE; HUMANS; HYPERTROPHY; LEUCINE; MYOCARDIUM; POLYSACCHARIDE-LYASES; RATS; RECOMBINANT PROTEINS;

EID: 0030061809     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.4.810     Document Type: Article

References (34)

1. 1-adrenoreceptor-mediated hypertrophy of rat cardiac myocytes. J Clin Invest. 1987;80:1194-1199.
2. Baker KM, Aceto JF. Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells. Am J Physiol. 1990;259: H610-H618.
3. Parker TG, Parker SE, Schneider MD. Peptide growth factors can provoke 'fetal' contractile protein gene expression in rat cardiac myocytes. J Clin Invest. 1990;85:507-514.
4. Parker TG, Chow KL, Schwarz RJ, Schneider MD. Differential regulation of skeletal α-actin transcription in cardiac muscle by two fibroblast growth factors. Proc Natl Acad Sci U S A. 1990;87: 7066-7070.
5. Ito H, Hiroe M, Hirata Y, Tsujino M, Adachi S, Shichiri M, Koike A, Nogami A, Marumo F. Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Circulation. 1993;87:1715-1721.
6. Adachi S, Ito H, Akimoto H, Tanaka M, Fujisaki H, Marumo F, Hiroe M. Insulin-like growth factor-II induces hypertrophy with increased expression of muscle specific genes in cultured rat cardiomyocytes. J Mol Cell Cardiol. 1994;26:789-795.
7. Ito H, Hirata Y, Adachi S, Tanaka M, Tsujino M, Koike A, Nogami A, Marumo F, Hiroe M. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest. 1993;92:398-403.
8. Jackson RL, Busch SJ, Cardin AD. Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol Rev. 1991;71:481-539.
9. Gallagher JT, Lyon M, Steward WP. Structure and function of heparan sulphate proteoglycans. Biochem J. 1986;236:313-325.
10. Castellot JJ, Favreau LV, Karnovsky MJ, Rosenberg RD. Inhibition of vascular smooth muscle cell growth by endothelial cell-derived heparin: possible role of a platelet endoglycosidase. J Biol Chem. 1982;257:11256-11260.
11. Groggel GC, Marinides GN, Hovingh P, Hammond E, Linker A. Inhibition of rat mesangial cell growth by heparan sulfate. Am J Physiol. 1990;258:F259-F265.
12. Floege J, Eng E, Young BA, Couser WG, Johnson RJ. Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis. Kidney Int. 1993;43:369-380.
13. Wright TJ, Pukac LA, Castellot JJ, Karnovsky MJ, Levine RA, Kim PH, Campisi J. Heparin suppresses the induction of c-fos and c-myc mRNA in murine fibroblasts by selective inhibition of a protein kinase C-dependent pathway. Proc Natl Acad Sci U S A. 1989;86: 3199-3203.
14. Wright TJ, Johnstone TV, Castellot JJ, Karnovsky MJ. Inhibition of rat cervical epithelial cell growth by heparin and its reversal by EGF. J Cell Physiol. 1985;125:499-506.
15. Sadoshima J, Xu Y, Slayter HS, Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 1993;75:977-984.
16. Sadoshima J, Izumo S. Mechanical stretch rapidly activates multiple signal transduction pathway in cardiac myocytes: potential involvement of an autocrine/paracrine mechanism. EMBO J. 1993; 12:1681-1692.
17. Baker KM, Chemin MI, Wixson SK, Aceto JF. Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am J Physiol. 1990;259:H324-H332.
18. Simpson P, Savion S. Differentiation of rat myocytes in single cell cultures with and without proliferating nonmyocardial cells. Circ Res. 1982;50:101-116.
19. Ito H, Miller SC, Billingham ME, Akimoto H, Torti SV, Wade R, Gahlmann R, Lyons G, Kedes L, Torti FM. Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vitro and in vivo. Proc Natl Acad Sci U S A. 1990;87:4275-4279.
20. Akimoto H, Bruno NA, Slate DL, Billingham ME, Torti SV, Torti FM. Effect of verapamil on doxorubicin cardiotoxicity: altered muscle gene expression in cultured neonatal rat cardiomyocytes. Cancer Res. 1993;53:4658-4664.
21. Gilles RJ, Didier N, Denton M. Determination of cell number in monolayer cultures. Anal Biochem. 1986;159:109-113.
22. Westergren-Thorsson G, Önnervik PO, Fransson LÅ, Malmström A. Proliferation of cultured fibroblasts is inhibited by L-iduronate-containing glycosaminoglycans. J Cell Physiol, 1991;147:523-530.
23. Castellot JJ, Wong K, Herman B, Hoover RL, Albertini DF, Wright TC, Caleb BL, Karnovsky MJ. Binding and internalization of heparin by vascular smooth muscle cells. J Cell Physiol. 1985;124: 13-20.
24. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-160.
25. Schwart K, Bastie D, Bouveret P, Oliviéro P, Alonso S, Buckingham M. α-Skeletal muscle actin mRNAs accumulate in hypertrophied adult rat hearts. Circ Res. 1986;59:551-555.
26. Schiaffino S, Samuel JL, Sassoon D, Lompré AM, Garner I, Marotte F, Buckingham M, Pappaport L, Schwartz K. Nonsynchronous accumulation of α-skeletal actin and β-myosin heavy chain mRNAs during early stages of pressure-overload-induced cardiac hypertrophy demonstrated by in situ hybridization. Circ Res. 1989;64:937-948.
27. A receptor antagonist blocks cardiac hypertrophy provoked by hemodynamic overload. Circulation. 1994;89:2198-2203.
28. Simpson PC, Long CS, Waspe LE, Henrich CJ, Ordahl CP. Transcription of early developmental isogenes in cardiac myocyte hypertrophy. J Mol Cell Cardiol. 1989;5:79-89.
29. Sadoshima J, Jahn L, Takahashi T, Kulik TJ, Izumo S. Molecular characterization of the stretch-induced adaptation of cultured cardiac cells: an in vitro model of load-induced cardiac hypertrophy. J Biol Chem. 1992;267:10551-10560.
30. 1 receptor subtype. Circ Res. 1993;73:413-423.
31. Lee RJ. Nonpeptide angiotensin II receptor antagonists. Am J Hypertens. 1991;4:271S-272S.
32. Nugent MA, Karnovsky MJ, Edelman ER. Vascular cell-derived heparan sulfate shows coupled inhibition of basic fibroblast growth factor binding and mitogenesis in vascular smooth muscle cells. Circ Res. 1993;73:1051-1060.
33. Busch SJ, Martin GA, Barnhart RL, Mano M, Cardin AD, Jackson RL. Trans-repressor activity of nuclear glycosaminoglycans on Fos and Jun/AP-1 oncoprotein-mediated transcription. J Cell Biol. 1992; 116:31-42.
34. Au YPT, Dobrowolska G, Morris DR, Clowes AW. Heparin decreases activator protein-1 binding to DNA in part by posttranslational modification of Jun B. Circ Res. 1994;75:15-22.